Board summary
Key figures
31,640
Registered population
62.6% aged 18–64
17.9%
Aged 65+
ICB 20.0% · England 17.9%
6.4%
Ethnic minority (non-White)
3.2% Asian · England 9.6%
78.8%
In IMD quintile 1
ICB 30.6% · England 21.0%
~21,371
Core20 residents (est.)
Resident basis; registered basis ~26,120 · see page 3
5,817
Hypertension register
+5.55% in 3 yrs · England +5.60%
660
SMI register
21.6% of Blackpool (LAD)'s
1,352
COPD register
Reviews +27.48% in 3 yrs
Forecast to 2030
6,331
Hypertension patients, 2030
+514 on today
66.4%
QRISK ≥20% on statins, 2030
+1.14pp over 3 yrs
3.9%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma annual reviews trail England benchmark.
Coverage is 60.9% (England 65.7%), leaving about 970 of 2,487 patients unreviewed alongside 2,680 asthma items per 1,000 aged 5-19 (England 1,488).
SMI physical health checks lag behind benchmarks.
On a 660-patient register (2.0% vs England 1.0%), blood pressure (73.2% vs 83.4%), BMI (65.4% vs 82.1%) and alcohol checks (66.4% vs 81.8%) trail.
COPD annual reviews and infant vaccines lead.
COPD reviews rose +27.5% to 83.9% (England 76.4%), and 12-month 6-in-1 vaccine coverage reached 96.9% (England 91.0%), exceeding the 95.0% target.
Population, age and ethnicity
Working-age males are elevated at 34.4% while older patients match England at 17.9%
Across 31,640 registered patients, males aged 18–64 account for 34.4%, above Blackpool (LAD) (30.7%), the ICB (30.0%) and England (31.1%). Patients aged 65+ represent 17.9% (5,678 patients), below Blackpool (LAD) (20.4%) and the ICB (20.0%), in line with England (17.9%). The catchment is 93.6% White, compared with 94.7% in Blackpool (LAD), 87.8% across the ICB and 81.1% in England, leaving a 6.4% ethnic minority share. Age figures use registered lists, whereas ethnicity reflects Census usual residents in associated areas rather than practice coding. This elevated working-age male cohort could alter primary care access patterns, testable by appointment booking audits.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackpool (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackpool LA) | 1,647 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 77.5% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 55.9% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackpool LA) | 955 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackpool LA) | 16.9 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
The PCN averages IMD decile 2.0 with 78.8% of registered patients in Core20
The PCN averages IMD decile 2.0 (Blackpool (LAD) 2.8, ICB 5.0, England 5.5), with 78.8% of registered patients in the Core20 cohort (England 21.0%). Concentration reaches 100.0% at South King Street Medical Centre (6,272 patients), while volume peaks at Adelaide Street Surgery (11,781 estimated patients, 81.0%). Practice estimates sum to 26,120 registered patients against 21,371 resident decile 1 and 2 individuals, requiring denominator reconciliation before targeted outreach. Widespread deprivation requires whole-PCN Core20 pathways alongside targeted support for practices with the highest patient volume.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
660
SMI register
2.00% recorded prevalence
190
Learning disability register
0.57% recorded prevalence
31
Care homes, 731 beds
In the PCN catchment
10.9%
Provide unpaid care
Blackpool (LAD), Census 2021
The PCN records 660 severe mental illness patients (2.0% prevalence vs Blackpool (LAD) 1.7%, ICB 1.2%, England 1.0%; 21.6% of borough cases) and 190 learning disability patients (0.6%, matching England 0.6%). Catchment care homes total 31 with 731 beds, though resident registrations are unverified. Higher severe mental illness prevalence could increase physical check demand, testable by annual review audits.
Severe mental illness: physical health checks
Across 660 severe mental illness patients (2.0% vs England 1.0%), checks trail England for blood pressure (73.2% vs 83.4%), alcohol recording (66.4% vs 81.8%), and BMI (65.4% vs 82.1%). This pattern could reflect recall gaps, testable by audit.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,817
Hypertension register
+5.55%
Register growth, 3 yrs
Blackpool (LAD) +5.85% · England +5.60%
−0.19pp
BP control, under 80
≤140/90 · −3.27pp aged 80+
+514
More patients by 2030
Forecast 6,331 (19.60%)
Hypertension case-finding and control
Hypertension prevalence is 17.6% (5,817 patients), above England (15.2%) and NHS Lancashire and South Cumbria Integrated Care Board (17.2%) but below Blackpool (LAD) (19.4%). Recent blood pressure recording reaches 87.6% (England 90.0%). Treatment to target is 65.7% (England 70.3%, Blackpool (LAD) 71.3%). For patients under 80, control is 62.8% (England 67.8%), spanning from 61.2% at Adelaide Street Surgery to 64.1% at St Pauls Medical Centre. Control for patients aged 80 and over is 78.7% (England 81.2%), having fallen 4.0% over 2023 to 2025 (England +2.2%). The register implies an unconfirmed base. Lower control across age cohorts could reflect recall or titration gaps, testable by clinical audit.
Lipids and statins
Lipid therapy reaches 64.0% for QRISK ≥ 20% (England 63.6%, Blackpool (LAD) 62.5%), with 2023 to 2025 growth of +1.8% trailing England (+6.2%). For patients aged 40 and over with diabetes and no history of CVD, statin uptake is 70.6% (England 73.2%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 77,286 | £1.40 | £1.64 | £1.86 | £108,200 |
| Cardiovascular (all), 2025 | 113,022 | £2.73 | £3.38 | £3.33 | £308,550 |
In 2026, the PCN prescribed 77,286 lipid-regulating items at £1.40 per item, below England (£1.86) and Blackpool (LAD) (£1.49), spending £35,552 less than at England's unit cost across 77,286 items. Unit cost is not an indicator of prescribing efficiency.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+8.85%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+1.30%
Asthma prevalence, PCN 3-yr % change
COPD reviews rose +27.5% over 2023 to 2025 to 83.9% (England 76.4%, Blackpool (LAD) 75.6%) on 1,352 patients (4.1% prevalence). Conversely, asthma reviews reach 60.9% across 2,487 patients (England 65.7%, Blackpool (LAD) 62.1%), leaving about 970 patients unreviewed. Prescribing for ages 5-19 reaches 2,680 items per 1,000 (England 1,488, Blackpool (LAD) 2,416). Slower review completion could reflect recall gaps, testable by clinical audit.
Cancer register and children's immunisation
While 12-month 6-in-1 immunisation is 96.9% (England 91.0%), age-5 coverage is lower: MMR dose 2 is 85.7%, which is 7.2 pp below dose 1 (92.9%), and the 4-in-1 booster is 81.6% (13.4 pp below the 95.0% target). Cancer register prevalence is 3.5% (England 3.8%). Lower pre-school uptake could reflect recall drop-off, testable by vaccination audits.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
In NHS Lancashire and South Cumbria ICB, 52.4% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (4,642 of 8,863 staged cases), trailing England (55.3%) and 22.6 pp below the 75.0% ambition by 2028. Staging is ICB-level only. Locally, cervical screening coverage in women aged 25-49 is 50.2% (England 66.8%), falling 5.5% over 2023 to 2025 (England -1.0%), while breast screening coverage is 51.5% (England 69.9%). Recorded cancer prevalence is 3.5% (England 3.8%), with three-year growth of +5.4% trailing England (+9.0%). Lagging screening coverage could delay early detection, making systematic recall audits a priority.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
For July 2026 (provisional), Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the cancer 62-day referral to treatment standard (85.0% standard), trailing Lancashire Teaching Hospitals (75.0%), University Hospitals of Morecambe Bay (72.4%), NHS Lancashire and South Cumbria Integrated Care Board (73.6%), and England (71.2%). The trust reached 71.4% on 28-day faster diagnosis (standard 75.0%; England 79.3%) and 98.0% on 31-day combined treatment (standard 96.0%). Diagnostic 6+ week waits across all 15 tests stood at 26.5% (England 23.1%), including non-obstetric ultrasound at 27.6%, MRI at 21.8%, and CT at 16.5%. Provider waits describe system access rather than PCN performance.
| Pathways within standard (%) | Blackpool | Lancashire | of Morecambe Bay | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.38 | 82.90 | 78.39 | 78.39 | 79.32 |
| 31-day treatment (96%) | 97.96 | 89.43 | 95.22 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 67.48 | 75.04 | 72.35 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Blackpool | Lancashire | of Morecambe Bay | England |
|---|---|---|---|---|
| MRI | 21.80 | 2.41 | 4.04 | 21.40 |
| CT | 16.49 | 14.97 | 13.76 | 9.92 |
| Echocardiography | 7.57 | 13.85 | 10.55 | 28.48 |
| Colonoscopy | 13.08 | 0.00 | 0.60 | 30.83 |
| Gastroscopy | 12.47 | 0.00 | 1.45 | 29.02 |
| All 15 DM01 tests | 26.54 | 26.65 | 10.44 | 23.14 |
| Community services activity | Blackpool residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 28,770 | 193,720 |
| Referrals | 4,700 | 29,855 |
| Patients with a contact | 8,925 | 65,335 |
Community services (residents of Blackpool), Jun 2026 (provisional). Experimental community services data for June 2026 (provisional) recorded 3,335 care activities for Blackpool local authority residents, within 533,345 activities reported across NHS Lancashire and South Cumbria Integrated Care Board. These figures capture submitting provider activity across resident administrative areas rather than unique registered PCN patients, and provider-to-PCN flows cannot be confirmed from this dataset.
Practice variation and patient experience
Practice phone access spans 41.8 pp and childhood vaccination domain achievement spans 45.0 pp
Overall QOF achievement is 92.3% at Adelaide Street Surgery, 91.7% at South King Street Medical Centre, and 96.8% at St Pauls Medical Centre (England 92.5%). Vaccination achievement spans 45.0 pp, from 26.4% at South King Street Medical Centre to 71.4% at St Pauls Medical Centre (England 55.2%), while clinical domain achievement is 98.6% at Adelaide Street Surgery (England 97.1%).
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| South King Street | 113 | 100.0 | 75.7% | 80.4% | 84.4% |
| Adelaide Street | 98 | 81.0 | 33.9% | 66.1% | 60.9% |
| St Pauls | 97 | 74.5 | 48.1% | 87.3% | 54.8% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Fifteen of 25 measures trail England's three-year change, led by physical health checks
Across 25 monitored measures, 15 trail England's three-year change. The widest lags appear in physical checks for severe mental illness: alcohol recording fell 0.8 pp over three years (England +5.4 pp) to 66.4% (England 81.8%), while blood pressure checks reached 73.2% (England 83.4%) and BMI recording reached 65.4% (England 82.1%). Blood pressure control in patients aged 80 and over fell 4.0% (England +2.2%). Conversely, annual COPD reviews rose +27.5% over three years (England +2.8%). This pattern could reflect follow-up gaps, testable by clinical recall audits.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Alcohol record (psychosis)
BP control, 80+
Cervical screening
QRISK statin treatment
Hypertension treated to target
COPD reviews
Asthma reviews
Breast screening (53-70)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackpool (LAD) | Asset | PCN | Blackpool (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 31 (731 beds) | n/a | Schools (catchment) | 33 | n/a |
| Children's centres | 7 | 13 | Places of worship | 37 | 62 |
| Libraries | 5 | 8 | Food banks (VCS) | 1 | 1 |
| Children and young people (VCS) | 1 | 1 | Primary schools (LA maintained) | 3 | 5 |
| Primary academies | 10 | 26 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Asthma annual review recall and prescribing
Asthma review coverage is 60.9% across 2,487 patients (England 65.7%, Blackpool (LAD) 62.1%, ICB 65.0%), leaving about 970 unreviewed alongside 2,680 asthma items per 1,000 aged 5-19 (England 1,488). For discussion: practices could run a single-template asthma recall prioritising high-prescribing cohorts and offering flexible review slots. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Combined SMI physical health check outreach
Across 660 SMI patients (2.0% vs England 1.0%; 21.6% of the borough register), checks lag England for BP (73.2% vs 83.4%), BMI (65.4% vs 82.1%), and alcohol (66.4% vs 81.8%, down 0.8 pp over 2023 to 2025). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Pharmacist-led hypertension titration and recall
Across 5,817 hypertension patients (17.6% vs England 15.2%), treatment to target is 65.7% (England 70.3%, Blackpool (LAD) 71.3%); under-80 control is 62.8% (England 67.8%), and 80+ control fell 4.0% over 2023 to 2025 to 78.7% (England 81.2%). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Working-age male access review (p2) | Male aged 18-64 | Neighbourhood health framework | PCN |
| Core20 list and outreach reconciliation (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check recall audit (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension recall and titration (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall outreach (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice access and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Asthma annual review recall and prescribing (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 Population | Core20PLUS5 respiratory | PCN |
| Option 2 · Combined SMI physical health check outreach (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Option 3 · Pharmacist-led hypertension titration and recall (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to target | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
